Peptron Inc (087010):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Peptron Inc (087010) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7625
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Peptron Inc (Peptron) is a developer and manufacturer of peptide and life science medicines. The company develops SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation. It provides peptide synthesis service, express service, protein conjugation for antibody production and affinity production service for antibody purification. The company’s products are used for the treatment of Parkinson’s disease, multiple system atrophy, type 2 diabetes, and non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. It sells products through a network of distributors across South Korea. Peptron is headquartered in Daejeon, South Korea.

Peptron Inc (087010) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptron Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Peptron Inc, Medical Devices Deals, 2012 to YTD 2018 9
Peptron Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Peptron Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Peptron Enters into Licensing Agreement with National Institute on Aging 11
Peptron Enters into Licensing agreement with National Institutes of Health 12
Equity Offering 13
Peptron Raises USD33 Million in Private Placement of Shares 13
Debt Offering 14
Peptron Raises USD24 Million in Public Offering of Bonds 14
Peptron Raises USD24 Million in Private Placement of Bonds 15
Peptron Inc – Key Competitors 16
Peptron Inc – Key Employees 17
Peptron Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Peptron Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptron Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptron Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Peptron Inc, Medical Devices Deals, 2012 to YTD 2018 9
Peptron Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Peptron Enters into Licensing Agreement with National Institute on Aging 11
Peptron Enters into Licensing agreement with National Institutes of Health 12
Peptron Raises USD33 Million in Private Placement of Shares 13
Peptron Raises USD24 Million in Public Offering of Bonds 14
Peptron Raises USD24 Million in Private Placement of Bonds 15
Peptron Inc, Key Competitors 16
Peptron Inc, Key Employees 17
Peptron Inc, Other Locations 18
Peptron Inc, Subsidiaries 18

List of Figures
Peptron Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptron Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptron Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Peptron Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Peptron Inc (087010):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apex Biotechnology Corp (1733)-医療機器分野:企業M&A・提携分析
    Summary Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and expo …
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • TPG Telecom Ltd (TPM):企業の財務・戦略的SWOT分析
    TPG Telecom Ltd (TPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Southern California Gas Co:企業の戦略的SWOT分析
    Southern California Gas Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • Luster Products Inc:企業の戦略・SWOT・財務情報
    Luster Products Inc - Strategy, SWOT and Corporate Finance Report Summary Luster Products Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kvaerner ASA (KVAER)-石油・ガス分野:企業M&A・提携分析
    Summary Kvaerner ASA (Kvaerner) is a provider of engineering, procurement and construction (EPC) services. It holds expertise in providing EPC services to steel substructures, topsides, concrete structures and onshore facilities. Its service portfolio includes project management, front-end engineeri …
  • Atos SE:企業のM&A・事業提携・投資動向
    Atos SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atos SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • G&K Services LLC:戦略・SWOT・企業財務分析
    G&K Services LLC - Strategy, SWOT and Corporate Finance Report Summary G&K Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Islet Sciences Inc (ISLT):企業の財務・戦略的SWOT分析
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • Cancer Research Technology Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • Pellegrini S.p.A.:企業の戦略・SWOT・財務分析
    Pellegrini S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Pellegrini S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CITGO Petroleum Corp:企業の戦略的SWOT分析
    CITGO Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • vTv Therapeutics Inc (VTVT)-製薬・医療分野:企業M&A・提携分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. The company’s pipeline products include azeliragon, TTP399, TTP273, HPP593, HPP737, HPP971 and hexokinase II inhibitors. I …
  • Penn Virginia Corp (PVAC):企業の財務・戦略的SWOT分析
    Penn Virginia Corp (PVAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • California Resources Corp (CRC):石油・ガス:M&Aディール及び事業提携情報
    Summary California Resources Corp (CRC) is an oil and gas company that explores for, produces, processes, gathers, and markets crude oil, natural gas and natural gas liquids. It has conventional and unconventional assets across major oil and gas basins such as San Joaquin, Los Angeles, Ventura and S …
  • Achaogen Inc (AKAO):企業の財務・戦略的SWOT分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel antibacterial treatments for the treatment of multi-drug resistant and gram-negative infections. The company’s lead product, plazomicin used for the treatment of serious bacterial infecti …
  • Xped Ltd (XPE):電力:M&Aディール及び事業提携情報
    Summary Xped Ltd (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. The …
  • Cleveland BioLabs Inc (CBLI)-医療機器分野:企業M&A・提携分析
    Summary Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein which acts as an agonist of …
  • Companhia Energetica de Minas Gerais – CEMIG:企業の戦略・SWOT・財務情報
    Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report Summary Companhia Energetica de Minas Gerais - CEMIG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆